Cargando…

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin

AIMS: Atrial fibrillation (AF) patients with contraindications to oral anticoagulation have had few options for stroke prevention. Recently, a novel oral anticoagulant, apixaban, and percutaneous left atrial appendage closure (LAAC) have emerged as safe and effective therapies for stroke risk reduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddy, Vivek Y., Akehurst, Ronald L., Armstrong, Shannon O., Amorosi, Stacey L., Brereton, Nic, Hertz, Deanna S., Holmes, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927063/ https://www.ncbi.nlm.nih.gov/pubmed/26838691 http://dx.doi.org/10.1093/europace/euv412

Ejemplares similares

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data
por: Reddy, Vivek Y., et al.
Publicado: (2019)

Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015)

The Canadian WATCHMAN Registry for Percutaneous Left Atrial Appendage Closure
por: Saw, Jacqueline, et al.
Publicado: (2023)

Watchman Left Atrial Appendage Closure After Incomplete AtriClip Closure
por: Ice, Daniel S., et al.
Publicado: (2022)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
por: Ke, Jin-Yan, et al.
Publicado: (2022)

Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings
por: Sakriss, Charlotte, et al.
Publicado: (2023)

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device
por: Halaby, Rim, et al.
Publicado: (2020)

Safety and Feasibility of Same-Day Discharge After Left Atrial Appendage Closure With the WATCHMAN Device
por: Tan, Bryan E-Xin, et al.
Publicado: (2021)

Impact of conscious sedation and general anesthesia on periprocedural outcomes in Watchman left atrial appendage closure
por: Kleinecke, Caroline, et al.
Publicado: (2021)

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
por: Alipour, Arash, et al.
Publicado: (2017)

Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry
por: Phillips, Karen P., et al.
Publicado: (2019)

Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females
por: Alhuarrat, Majd Al Deen, et al.
Publicado: (2023)

Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2019)

The Added Value of Preprocedural Cardiac Computed Tomography in Planning Left Atrial Appendage Closure With the Watchman FLX Device
por: Kassab, Joseph, et al.
Publicado: (2023)

Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
por: Fukuda, Nobuyuki, et al.
Publicado: (2022)

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage
por: Nandar, Phoo Pwint, et al.
Publicado: (2018)

Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019)

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium
por: Yano, Masamichi, et al.
Publicado: (2022)

Device-Associated Thrombus with Watchman FLX Left Atrial Appendage Closure Device: A Report of Two Cases
por: Dhaduk, Nehal, et al.
Publicado: (2023)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy
por: Marini, Massimiliano, et al.
Publicado: (2022)

Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device
por: Luani, Blerim, et al.
Publicado: (2017)

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry
por: Boersma, Lucas V.A., et al.
Publicado: (2016)

Small thrombi and incomplete endothelialization detected by cardiac endoscopy after left atrial appendage closure using Watchman device
por: Abe, Ryo, et al.
Publicado: (2020)

Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
por: Saad, Mohammed, et al.
Publicado: (2021)

A Comparative Study of Three Imaging Modalities for Size Selection of a Watchman Left Atrial Appendage Closure Device
por: Ruan, Zhong-bao, et al.
Publicado: (2022)

Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement
por: Ahuja, Tania, et al.
Publicado: (2019)

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device
por: Luani, Blerim, et al.
Publicado: (2019)

Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center
por: Xue, Xin, et al.
Publicado: (2018)

Left atrial appendage closure with Watchman device: Insights from the first-ever Tunisian experience and six-year follow-up
por: Chamtouri, Ikram, et al.
Publicado: (2021)

Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
por: Phillips, Karen P., et al.
Publicado: (2016)

Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
por: Prabhakar Bhat, Sangeeta, et al.
Publicado: (2021)

Correction to: Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device
por: Korsholm, Kasper, et al.
Publicado: (2022)

Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
por: Abelson, Mark
Publicado: (2013)

Personalized Fluoroscopic Angles in Watchman™ Left Atrial Appendage Closure Landing Zone Assessment: A Three-Dimensional Printed Simulation Study
por: Shee, Vikram, et al.
Publicado: (2020)

Remaining Challenges With Transcatheter Left Atrial Appendage Closure
por: Alkhouli, Mohamad, et al.
Publicado: (2020)

Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
por: Brouwer, Tom F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jogt5b7e8ik31bed8t7rk3q16